High Enrollment and Representativeness of MACS and WIHS Study Participants in the newly merged MACS/WIHS Combined

Gypsyamber D'Souza1, Ryan Herrschaft1, Phyllis C Tien1

  • 1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland (Gypsyamber D'Souza, Ryan Herrschaft, Sabina Haberlen) Department of Medicine, Johns Hopkins University, Baltimore, Maryland (Todd T Brown, Jacquett R Batson) Department of Medicine, University of California San Francisco, San Francisco, California (Phyllis C Tien) Department of Medicine, Johns Hopkins University, Baltimore, Maryland (Todd T Brown) Department of Medicine/ Division of Infectious Diseases, Georgetown University (Seble G Kassaye) Department of Medicine, Albert Einstein College of Medicine, Bronx, New York (Anjali Sharma). Department of Medicine/Division of Infectious Diseases, Stroger Hospital of Cook County Health(Audrey L French) Department of Oral and Maxillofacial Surgery, College of Dentistry, New York University, (Brad Aouizerat) Department of Medicine and Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Valentina Stosor) Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Catalina Ramirez) Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine (Igho Ofotokun) Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California (Matthew Mimiaga) Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA (Charles Rinaldo) Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine (Margaret Fischl) Schools of Nursing, Public Health and Medicine, University of Alabama at Birmingham (Mirjam-Colette Kempf).

Abstract

No abstract available in PubMed .

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
617
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

2.5K
Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
499
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
686